# Cytokine-induced Memory-like NK Cells in Patients With Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)

> **NCT01898793** · PHASE1,PHASE2 · TERMINATED · sponsor: **Washington University School of Medicine** · enrollment: 89 (actual)

## Conditions studied

- Leukemia, Myeloid, Acute

## Interventions

- **DRUG:** Fludarabine
- **DRUG:** Cyclophosphamide
- **PROCEDURE:** Leukapheresis
- **BIOLOGICAL:** Cytokine-induced killer cells
- **BIOLOGICAL:** IL-2
- **DRUG:** ALT-803
- **PROCEDURE:** Peripheral blood for correlative studies
- **PROCEDURE:** Bone marrow for correlative studies

## Key facts

- **NCT ID:** NCT01898793
- **Lead sponsor:** Washington University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-08-11
- **Primary completion:** 2021-12-28
- **Final completion:** 2022-04-04
- **Target enrollment:** 89 (ACTUAL)
- **Why stopped:** Insufficient funding/staff
- **Last updated:** 2024-01-17

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01898793

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01898793, "Cytokine-induced Memory-like NK Cells in Patients With Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01898793. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*